Detailed Notes on M3541
The higher distinction from placebo found to the IFN-high individuals supports the hypothesis which the peripheral blood IFN examination standing demonstrates systemic form I IFN activity. In contrast, for IFN-lower patients there was a scaled-down distinction in response rates amongst the placebo and the 200 mg or 1200 mg regular monthly sifalim